These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4275201)

  • 1. [Effect of a-sympathicolysis in Raynaud's syndrome].
    Westermann KW; Langbehn A; Feige A; Priester G
    Verh Dtsch Ges Inn Med; 1973; 79():1395-7. PubMed ID: 4275201
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sympatholytic effect of intra-arterial reserpine in sclerodermia and Raynaud's disease].
    Acevedo A; Palacios JM; López R; Palma F
    Rev Med Chil; 1984 Jun; 112(6):553-8. PubMed ID: 6515168
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymoxamine for Raynaud's disease and chilblains.
    Jaffe GV; Grimshaw JJ
    Br J Clin Pract; 1980; 34(11-12):343-6. PubMed ID: 6450602
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of vasodilator agents and of indirect heating in Raynaud's disease.
    Hansteen V
    Scand J Clin Lab Invest Suppl; 1973; 128():211-2. PubMed ID: 4764583
    [No Abstract]   [Full Text] [Related]  

  • 5. Raynaud's syndrome.
    Cooke ED; Nicolaides AN
    BMJ; 1990 Mar; 300(6724):553-5. PubMed ID: 1691027
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thermographic data in Raynaud's syndrome. Initial results in Lyon].
    Thiers H; Schmitt M; Fayolle J
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):462-4. PubMed ID: 5510745
    [No Abstract]   [Full Text] [Related]  

  • 7. Hexopal in Raynaud's disease.
    Aylward M
    J Int Med Res; 1979; 7(6):484-91. PubMed ID: 520652
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of Raynaud's Syndrome with prostacyclin.
    Belch JJ; Newman P; Drury JK; Capell H; Leiberman P; James WB; Forbes CD; Prentice CR
    Thromb Haemost; 1981 Jun; 45(3):255-6. PubMed ID: 7025341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double blind trial of UK-38,485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome.
    Rustin MH; Grimes SM; Kovacs IB; Cooke ED; Bowcock SA; Sowemimo-Coker SO; Turner P; Kirby JD
    Eur J Clin Pharmacol; 1984; 27(1):61-5. PubMed ID: 6386490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laser Doppler spectral analysis of patients with Raynaud's phenomenon during a standardized thermal test].
    Léger P
    Ann Dermatol Venereol; 1998 Nov; 125 Suppl 2():S28-9. PubMed ID: 9922888
    [No Abstract]   [Full Text] [Related]  

  • 11. Raynaud's disease. Cold hands, slowed blood flow.
    Mayo Clin Health Lett; 2007 May; 25(5):7. PubMed ID: 17595712
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of thymoxamine in primary Raynaud's phenomenon.
    Grigg MJ; Nicolaides AN; Papadakis K; Wolfe JH
    Eur J Vasc Surg; 1989 Aug; 3(4):309-13. PubMed ID: 2527760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: the role of endothelin.
    Edwards CM; Marshall JM; Pugh M
    Clin Sci (Lond); 1999 Jun; 96(6):577-88. PubMed ID: 10334963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thermography in evaluating therapy in Raynaud's disease].
    Litmanovitch J; Shilo R; Chayen M
    Harefuah; 1972 Jun; 82(11):503-6. PubMed ID: 5068900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trial of a new drug in Raynaud's disease. Clinical and thermographic control].
    Dumoulin J
    Electrodiagn Ther; 1981; 18(4):168-74. PubMed ID: 6279383
    [No Abstract]   [Full Text] [Related]  

  • 16. [Raynaud's phenomenon in grinders. Apropos of 9 cases].
    Beurey J; Weber M; Prost C; Vadot J
    J Med Lyon; 1972 Sep; 53(232):1035-9. PubMed ID: 4638071
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution of a thermographic examination using an AGA apparatus in Raynaud's disease and Raynaud's syndrome].
    Zavrel B
    Cesk Radiol; 1983 Jun; 37(4):219-22. PubMed ID: 6883568
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of severe Raynaud's syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy.
    Cooke ED; Pockley AG; Tucker AT; Kirby JD; Bolton AE
    Int Angiol; 1997 Dec; 16(4):250-4. PubMed ID: 9543222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reserpine administration by retrograde intravenous route in patients with Raynaud's phenomenon].
    Acevedo A; Arinoviche R; Palma A; Olea E; Guzmán G; Arriagada M; Grisanti M; Testar R
    Rev Med Chil; 1982 Nov; 110(11):1063-5. PubMed ID: 7184095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.